Mochida Pharmaceutical Co Ltd banner

Mochida Pharmaceutical Co Ltd
F:MFY

Watchlist Manager
Mochida Pharmaceutical Co Ltd Logo
Mochida Pharmaceutical Co Ltd
F:MFY
Watchlist
Price: 16.9 EUR -2.31% Market Closed
Market Cap: €616.6m

Wall St Price Targets

MFY Price Targets Summary
Mochida Pharmaceutical Co Ltd

There are no price targets for MFY.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Mochida Pharmaceutical Co Ltd Competitors:
Price Targets
EVER
EverQuote Inc
10% Upside

Revenue
Forecast

2% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
2% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is -5%.

Gross Profit
Forecast

0% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
0% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is -3%.

Operating Income
Forecast

-2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Mochida Pharmaceutical Co Ltd

Pre-Tax Income
Forecast

-2% / Year
Past Growth
-28% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
-2% / Year
Past Growth
-28% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 2 years is -28%.

Net Income
Forecast

-1% / Year
Past Growth
-25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
-1% / Year
Past Growth
-25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 2 years is -25%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MFY's stock price target?
Not Available

MFY does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-5%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is -5%.

What is the Gross Profit forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is -3%.

What is the Pre-Tax Income forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-28%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 2 years is -28%.

What is the Net Income forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-25%

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 2 years is -25%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett